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Abstract    
 
Background: Few randomized trials have been carried out to evaluate the effect of lifestyle 
modifications on mammographic breast density (MBD). The randomized 2x2 factorial DAMA trial 
aimed to evaluate whether MBD can be reduced in post-menopausal women with high baseline 
MBD  by a 24-months dietary  and/or physical activity (PA) interventions. 
Methods: We randomized healthy post-menopausal women, attending  the Florence (Italy) 
mammographic screening program, aged 50-69 years, non-smokers, with MBD>50% and  no recent  
hormone therapy, to: a) a dietary intervention focused on plant-foods, with a low glycemic load, 
low in saturated fats and alcohol; b) a  PA intervention combining daily moderate intensity 
activities  and one weekly supervised session of more strenuous activity; c) both interventions; d) 
general recommendations. We evaluated changes in MBD  based on  VolparaTM estimates 
comparing  baseline and follow-up digital mammograms by an intention-to-treat-analysis. 
Results: MBD measures were available for 226 participants. An interaction emerged between 
treatments and thus we run analyses by arms. A decrease in volumetric percent density emerged for 
women in the dietary intervention (ratio 0.91; 95%CI 0.86-0.97; p=0.002) and in the PA 
intervention arm (0.93; 95%CI 0.87-0.98; p=0.01) in comparison with controls. No clear  effect 
emerged in the double intervention arm.  
Conclusions: This intervention trial suggests that a  24-months dietary or PA intervention may 
reduce MBD in postmenopausal women.  
Impact: A modification of   dietary habits or an increase in PA in  postmenopausal women may 
reduce MBD. Further studies are needed to confirm these findings for planning breast cancer  
preventive strategies. 
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Introduction   
Most  factors that  modulate breast cancer risk including age, reproductive and family history  
cannot be modified. However, potentially modifiable lifestyle risk factors  have been identified as 
well (1,2), suggesting specific strategies to reduce  breast cancer  incidence in the general female 
population or in subgroups at increased risk. 
The extent of mammographically detected fibroglandular breast tissue, or mammographic breast 
density (MBD), is a strong and independent risk factor for breast  cancer (3). MBD has been 
consistently associated with increased breast cancer  risk in studies using different methods of MBD  
evaluation ranging from subjective evaluation by trained radiologists, to fully automated methods 
allowing to obtain quantitative measures of breast density, and in studies based either on films or 
digital mammograms (3,4). Recent studies evaluating the association between the Breast Imaging 
Reporting and Data System (BI-RADS) classification of MBD, the most widely used in clinical 
settings, reported  at least a two fold increase in risk in women  with breast  density >50%  (5,6).  
Most established  risk and protective factors for  breast cancer  act in the same direction in 
modulating  MBD, except age and body mass index (BMI) for which associations are in the 
opposite direction. It is well known that MBD declines with increasing age,  particularly during the 
menopausal transition, while  BMI is  inversely associated with MBD. Studies including MBD 
assessment should collect information on anthropometry, particularly  longitudinal studies  in which 
weight changes occur (7,8). 
MBD may be modified  by hormonal aspects  (9,10)  and the reduction of MBD was 
associated in some studies with reduced risk  of breast cancer development or recurrence (10,11, 
12) thus suggesting the possibility to use MBD as a biomarker of the effect of interventions aimed 
to decrease breast cancer  risk.   
Lifestyle habits have also been investigated as possible modulators of MBD. Studies aimed 
to investigate the role of dietary habits and physical activity (PA) have been mostly observational, 
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with a  cross sectional design, and have shown mixed results  possibly in relation to differences in 
study design, study population, timing of the exposure and MBD assessment (13,14).  
Randomized intervention trials in which behavioural changes in dietary and PA habits are proposed 
to participants, with an adequate  control group  for comparison, can help in understanding the 
potential  modifying effect on  MBD  and contribute to evaluate the role of lifestyle habits in 
lowering breast  cancer risk. So far, few and mostly short- term intervention trials  have been 
carried out mainly aimed to evaluate specific lifestyle aspects (15-19). 
We have designed  and carried out the DAMA (Diet, physical Activity  and MAmmography) study, 
a 24-months randomized 2x2 factorial trial aimed at investigating whether a dietary intervention 
based on plant-foods, with a low glycemic load, low in saturated fats and alcohol, and rich in 
antioxidants, and/or a PA intervention based on an increase of moderate PA levels, were able to 
reduce MBD in post-menopausal women with high MBD (>50%) (20).  
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Material and Methods  
 
Study design and hypothesis 
 
The DAMA study is a single-centre, randomized intervention trial with a 2x2 factorial design  (Trial 
Registration ID: ISRCTN28492718). We have already described the  study  protocol in detail (20). 
Briefly, the hypothesis tested in this study  is that MBD can be reduced in healthy post-menopausal 
women with high-MBD (>50%) by modifying their dietary habits and/or PA level in a 24-months 
intervention period.  
The DAMA trial was approved by the Ethics Committee of the Local Health Authority in Florence 
(Italy). All study participants signed an informed consent form. The study was conducted in 
accordance with the Declaration of Helsinki.  
 
Selection of study participants 
We selected study participants among women  attending the local  screening programme  in  
Florence  (21). Women potentially eligible  were aged between 50 and 69 years, had a negative 
screening mammogram showing  a MBD of 50% or more,  as assessed routinely in the  screening 
programme applying the BI-RADS classification (22). We excluded from the study women selected  
for a second-stage diagnostic procedure after a screening mammogram, regardless of the final 
outcome of the diagnostic process. 
Exclusion criteria included: pre- or peri-menopausal status (at least one menstrual cycle during past 
12 months); recent (past 12 months) hormone therapy use;  being a current smoker (or a former 
smoker  for less than 6 months); a previous diagnosis of cancer (except non-melanocytic skin 
cancer); diabetes or other major co-morbidities,  including major cardiovascular and neurological 
diseases, severe hip or knee osteoarthritis, able to hamper  an active participation in the study. We 
recruited participants  between  February 2009 and  March 2010.  
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Baseline visit and randomization  
Trained personnel measured weight, height, hip and waist circumference through 
standardized procedures and collected information on dietary habits and lifestyle including PA 
using questionnaires previously used in the frame of the EPIC study  (European Prospective 
Investigation into Cancer and Nutrition). The  Food Frequency Questionnaire (FFQ), specifically 
validated for the Italian dietary habits, allowed to collect  data on frequency of consumption of a 
large variety of food items and the quantity of the food consumed through the selection of an image 
of a food portion, or considering a standard portion when no image was provided.  The  
consumption of alcoholic beverages was also collected (23) .  
The EPIC Lifestyle Questionnaire  (LSQ) includes a section, aimed to assess PA at work and during 
leisure time, validated in ad hoc studies (24).  PA at work was classified according to the following 
categories: sedentary, standing, manual or heavy manual work. Information on  leisure time 
activities includes recreational  activities (walking, biking and fitness activities) and  household 
activities (hours spent in do-it-yourself activities, gardening, and  house cleaning). 
After completion of the baseline visit, we randomized each woman to one of the four arms of the 
study (diet, PA, diet+PA, control) through permuted-block randomization stratified by age (50-59 
years, 60-69 years) and Body Mass Index category (< 25 kg/m
2, ≥ 25 kg/m2), with a constant block 
size (n=4).  
 
Intervention 
Dietary intervention (arm 1). Each woman was asked to gradually adopt a diet mainly based on 
plant food, with a low glycemic load, low in saturated- and trans-fats and alcohol and rich in 
antioxidants. Overall, the aim of the intervention was to change the  composition of diet  in an 
isocaloric context (without specific advices on the quantity of food to be consumed). The 
intervention  objectives were: a) substitution of refined grains with wholegrains; b) consumption of 
at least one portion of raw and one portion of cooked vegetables at each meal;  c) consumption of 
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fish at least two-three times weekly; d) consumption of fresh and processed red meat reduced to less 
than 1 time/week considering all types e) at least three-four portions/week of legumes and pulses; f) 
consumption of two- three portions/day  of fruit; g) cakes and desserts reduced to a maximum of 1 
portion/week; h) no more than 1 portion/day of milk or yogurt and 2 portions/week of cheese. 
Exclusion of full fat varieties; i) extra-virgin olive oil as the only dressing  and cooking fat;  j) no 
more than one glass of wine per day, at meals, if already used to drink wine (20).  
After an initial individual counselling,  participants were requested to attend six group meetings and 
eight  cooking classes during the two years of the study. The aim of both group sessions and 
cooking classes was to clarify the details of what was being requested from study participants and to 
enhance their motivation and adherence to instructions received.  
Physical activity intervention (arm 2).  The aim was to increase moderate daily recreational 
activities up to 1 hour/day, corresponding to about 3 MET-hours/day (MET=Metabolic Equivalent) 
to be combined with a more strenuous activity accounting for 6-10 MET-hours/week. Each woman 
assigned to this arm discussed, how to adapt requested changes in levels of PA to her lifestyle and 
daily schedule during an initial individual counselling session with a PA expert.  
 Suggested activities to be included in the daily routine were walking at moderate pace, biking, 
etc. We provided also some equipment for home exercises. Women were also requested to attend 
weekly a one-hour session led by trained PA experts in an appropriate fitness facility (up to a 
maximum of  97 sessions  over the 24-months period). The study protocol also included 
participation to six group sessions and six collective walks supervised by the study team (20). 
Dietary+Physical activity intervention (arm 3). Participants were asked to change both their 
dietary and PA habits by combining arms 1 and 2 protocols and activities as described above.  
We requested  study participants assigned to any of the intervention arms to keep five written 
one-week diaries on diet (arm 1), PA (arm 2), or both (arm 3). The study personnel reviewed the 
diaries  in order to monitor the achievement of study objectives and to discuss  individually the 
difficulties encountered by participants.  
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Control group (arm 4). Women in  this arm received  general advices on healthy dietary and 
PA patterns according to the WCRF 2007 recommendations. We organized a  group meeting 
within the first six months of the study and  distributed ad hoc printed material.  
 
 
Final visit 
We invited  all  women  for a visit 24  (±3) months after their enrolment into the study in the same 
period in which they underwent their routine screening mammographic examination. We applied 
the same protocol including the FFQ and the LSQ and the anthropometric measurements.  
 
Outcome measures  
The change in volumetric percent density (VPD) between baseline and  the end of the study  was 
the  main outcome  of the DAMA study. We planned to perform the follow-up mammogram in a 
specific time-window (24+3 months after randomization). Both baseline and follow- up 
mammograms were performed in the frame of the local screening program with the same digital 
mammography equipment (GE Senographe® 2000D).  
VPD was measured on the raw data from full-field digital mammograms collected in the study 
using the fully-automated VolparaTM density software (version 3.1, Matakina Technology, 
Wellington, New Zealand). The technical characteristics of Volpara system has been already 
described in details (25). Briefly,  the algorithm computes the thickness of dense tissue  at each 
pixel using the X-ray  attenuation of an entirely fatty region as an internal reference. The thickness 
values over the whole breast region are integrated to obtain the absolute dense volume (cm
3
). Total 
breast volume (cm
3
)  is obtained by multiplying the breast area by the recorded breast thickness, 
corrected for the breast edge. Volumetric percent density  (VPD) is then  obtained from the ratio of 
the two measures. In the present study we  used the average VPD obtained from mediolateral  
oblique and craniocaudal  views of the right and left breasts.  
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Sample size  
According to the original factorial design with this  sample size we estimated to be  able  to 
detect, with a two-sided 0.05 alpha  level and a power of 0.90, percent MBD difference of 0.43*SD 
between either intervention and control groups (e.g. with a SD=10.0%, we estimated to be able to 
identify a  difference of 4.3%).  
 Statistical analyses   
We compared the main characteristics of the study participants at baseline by arms, 
including data on dietary habits and PA habits obtained  through the FFQ and LSQ respectively 
using  analysis of variance (ANOVA) for quantitative variables. The chi-square test was utilized for 
categorical variables. 
The main outcome analysis was performed on an intention-to-treat basis. The factorial 
design allows to evaluate separately the effect of dietary or PA intervention  comparing the two 
groups receiving the same treatment with the two groups not receiving that treatment. Therefore, to 
evaluate the effect of dietary intervention we compared  subjects randomized to arms 1 and 3 versus  
arms 2 and 4 while we evaluated the effect  of the  PA intervention comparing subjects randomized 
to arms 2 and 3 versus arms 1 and 4. 
VPD values  were log-transformed in order to normalize the distribution. For each treatment group 
the ratio, and 95% Confidence Intervals, of follow-up VPD value in comparison with the  control 
group were estimated  through a  general linear model with log-transformed follow-up VPD values 
as outcome, treatment groups as exposure and  the baseline mammographic VPD measure (on log 
scale), weight changes occurred in the intervention period  and the randomization block variables  
(age and BMI)  as covariates. 
We evaluated the presence of an interaction between the two treatments considered in the factorial 
design and we run a  a secondary analysis by arms as suggested by McAlister and others (26,27). 
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We evaluated changes in selected food consumption and  in PA habits between end of study 
and baseline between each intervention arm and control arm using questionnaire data  through  a 
general linear model analysis. The analyses were performed using SAS (SAS/STAT version 9.2) .                    
 
Results 
We recruited and  randomized 234 women (18.4% of women selected  from the screening 
mammographic files and 30.4% of the women defined as eligible after a specific interview). The  
most frequent  reasons given by women who refused to participate were  lack of time or  lack of 
interest in the proposed intervention (Figure 1). 
All randomized women performed the planned screening mammogram at the end of the 
intervention period.  The mean interval between this mammogram and the baseline mammogram  
was 2.2 (SD 0.2) years. We identified  both baseline and end of study mammograms of all women, 
however for eight of them it  was impossible to retrieve the raw data for the VolparaTM  
measurements due to technical problems in imaging storage system. Therefore, the present analysis  
is based on 226 women for which raw data of both baseline and end of study digital mammograms 
were available. For all these women information collected at baseline and end of study visits were 
available and the mean interval  between the two visits was  2.0 years (SD 0.1). 
The mean age of participants was 58.7 year (SD 5.2), with 42% reporting  a high  school  degree.  
Most participants  were never smokers and with a BMI <25. Among  women  with a paid  work 
(57.5%) most reported a sedentary work. Approximately 69% reported  to have never  used 
hormone therapy  (Table 1). 
The randomized groups were similar at baseline for these and other listed variables including those 
related to dietary and PA habits at baseline except some differences in reported consumption of a 
few selected items (cheese and cakes). 
Based on data obtained  in the baseline and final visits we first  evaluated if any change in weight, 
potentially affecting breast density measures, occurred. Overall participants experienced an average 
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weight loss of approximately 0. 38 kg; (SD 2.9) the weight loss was more evident in the PA+dietary 
intervention arm (0.54 kg ; SD 2.6) and less evident in the control arm  (0.20 kg; SD2.6). However, 
no significant differences  between arms emerged.  
At baseline 202 women (89.3%)  were classified in BI-RADS category 3 (51%-75% fibroglandular 
tissue) and 24 (10.7%)  in BI-RADS category 4 (>75%  fibroglandular tissue) by the local  
screening radiologists. No differences in BI-RADS classification distribution  emerged by arms 
(p=0.39).  Overall, the median  VPD at baseline automatically estimated through Volpara software  
was 14.0%  (IQ 10.3- 18.9) and the mean was 15.0% (SD 5.6). No significant differences emerged 
by arms although we observed a lower mean VPD value in women randomized to the double 
intervention arm (mean 13.9%;SD 5.8). 
 
Main outcome results 
Analyses by the two main treatments  showed no statistically significant effect, although  there was 
some evidence of a modest reduction in VPD. However a clear  interaction  between the two 
treatments emerged  ( p= 0.01) supporting the need  for analyses by single arms. In Figure 2 we 
show  the unadjusted geometric means of volumetric percent density in each arm at baseline and 
follow-up. We observed a percent reduction in VPD measured in follow-up mammograms in 
comparison with baseline  in the dietary and in the PA intervention arms (4.7% and 5.1%  
respectively) (see also Table 2).  
When analyses were carried out in comparison with the control arm by a model including terms for 
baseline VPD log-trasformed, weight changes occurred in the intervention period  and the 
randomization block variables  (age and BMI) as covariates,  a VPD reduction of approximately 9% 
for the dietary (ratio 0.91; 95% CI 0.86-0.97; p=0.003)  and  of 7% for  the   PA arm (ratio 0.93; 
95%CI 0.87-0.98; p=0.01)  emerged. Women in the  PA+diet arm showed a lower reduction in 
VPD (p=0.08) (Table 2).  
 No adverse effects related to the intervention protocols were reported. 
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Compliance with the proposed interventions 
The changes  in reported dietary and PA habits are shown in Table 3. An increase in vegetable and 
legumes consumption and a decrease in red meat and cakes consumption emerged in arms 1 and 3 
in comparison with the control group.  We also found an increase in reported hours/ week of all 
recreational activities, particularly walking and fitness activities in  both arm 2 and 3 in comparison 
with the controls. We performed an evaluation of the adherence to the protocol activities by arms. 
We observed a reduced participation to the supervised PA weekly sessions among women 
randomized to the double intervention arm  in comparison with women randomized to the PA arm 
(45.7% vs 57.3%; p= 0.02 ) No statistically significant differences emerged in participation to all 
other protocol activities although, overall, participation of women randomized to the double 
intervention arm was lower in  comparison with those in the single intervention arms. 
 
Discussion 
In this randomized  factorial trial aimed to investigate the effect of a 24-months dietary and/or PA  
intervention in reducing  breast density in healthy postmenopausal women with baseline  high 
breast density, we did not find a significant effect  of the two main treatments. When  we considered 
the  effects by single arms,  a significant reduction in VPD measures  clearly emerged in women 
randomized to the dietary  intervention and  in women randomized to the PA intervention. Overall, 
our results suggest that, in comparison with the control group, the women randomized to the dietary 
or the PA intervention arm experienced a reduction in VPD  between 9% and 7%. In contrast, in  
women randomized to the double dietary and PA interventions the reduction was lower and failed 
to reach the statistical significance.  
Studies on the modulating effects of diet and PA on breast density  have been  mostly observational 
and results are mixed. Some studies suggested positive associations with high intake of saturated 
fatty acids (28, 29), proteins and carbohydrates (30,31), alcohol  (32, 33, 34, 35), consumption of 
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sweet foods (36)
 
and with  the adherence to a
 
Western-style diet  (37). An inverse association with 
fiber and carotenoids (28), vitamin  D and calcium (38, 35) emerged in some studies, but these 
findings were not confirmed by others (39, 40, 41,42). Some studies reported an inverse  association 
with an increasing level of recreational activities (43,44,45)
 
, but others studies did not (46,47, 35). 
We have previously reported the results of a longitudinal study of 1,600  healthy women, carried 
out in the frame of  the EPIC Florence cohort, showing that a low alcohol  intake and a diet with a 
low glycemic load, rich in vegetables, olive oil as dressing fat (48,49) and a moderate PA  (50) were  
associated with a lower mammographic density pattern in a negative mammogram obtained five 
years after the assessment of lifestyle habits. 
To our best knowledge only one trial evaluated the effect of a  PA intervention in post menopausal 
women on breast density. In the ALPHA trial, a parallel group randomized trial,  sedentary 
postmenopausal women (n = 320) were randomized to aerobic exercise (45 minutes at 70% to 80% 
heart rate reserve, 5 days per week) or to a control group requested to maintain the usual PA level  
for 1 year. The intervention included both facility-based and home-based sessions. Overall, 
moderate to intense  aerobic activities were proposed. Changes in breast density measures, assessed 
in digitized mammograms obtained at baseline and 1 year after  were not  significantly different 
between the two groups (15). In  the ALPHA trial the  intervention appeared to be more structured, 
with  more intense activity sessions and  quite strictly monitored, while in our study women were 
invited to specific supervised session 1 hour/week and were requested to perform at least 1 hour 
/day of moderate intensity activity without supervision, with group walks and periodic diaries.  
Additional  differences  with our study also include selected characteristics of the study populations,  
the duration of intervention period and  different methods to assess breast density.  
Trials aimed to evaluate the effect of dietary modification on MBD  in postmenopausal 
women  are scanty and  mostly aimed to evaluate the effect of specific foods or food components 
rather then to evaluate the effect of a more comprehensive modification of dietary pattern. 
Randomized trials aimed to evaluate the effect of supplementation of  soy isoflavones (16,17,18) 
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did not find any effect on various MBD measures in postmenopausal women.  No effect on MBD 
emerged in a recently published randomized double blind placebo controlled trial  aimed to evaluate 
the effect of a green tea extract in healthy postmenopausal women with high MBD at baseline 
although in  younger women ( 50-55 years)  randomized to the green tea extract  supplementation 
arm there was some evidence of a reduction in MBD (19). 
The  effect of a two years low-fat and high-carbohydrate diet in an isocaloric context in 
comparison with the usual American diet,  was evaluated in a multicenter randomized trial 
involving healthy  women participating to mammographic screening programmes with a  
radiological breast density in more than 50% of the breast area. A reduction in the area of density 
emerged and was particularly evident  in women in menopause transition (51).  
We carried out a dietary intervention aimed to a modification of diet informed by updated 
recommendations for the prevention of cancer, providing  indication on food choices and frequency 
of consumption. It is difficult to compare our study to the previously described studies  although 
basically our intervention pointed to reduce  animal fats and proteins, to increase the consumption 
of  foods rich of antioxidants and fiber  and to replace  highly refined carbohydrate-based foods 
with wholegrain products.   
Although we supported an isocaloric change in diet  focusing on quality rather then on 
quantity of foods  and the PA intervention was based mainly on  moderate activities,  participants 
experienced some weight reduction, more evident in the intervention groups. Being aware of the 
possible effect of changes in weight on MBD measures, although  the entity of  these  changes was 
not significantly different between arms, we adjusted for individual change. 
While we observed a reduction in VPD in both dietary and PA single intervention  arms, we 
found only a  modest reduction in VPD in the double intervention arm.  Overall these findings  
emerged  as an  interaction between the two treatments thus supporting the need of a analysis by 
arms (26,27). While we can not exclude the role of chance, it is also possible that the heavier 
involvement requested to women randomized to the double  PA and dietary intervention  arm might 
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have resulted in a reduced adherence to the protocols as suggested by the lower  attendance to the 
weekly fitness supervised  session among these women  in comparison with women randomized to 
the PA intervention arm. Another aspect to be considered is that  in the  double intervention arm 
weight loss tended to be more pronounced  and  this aspect  might have spuriously affected VPD 
measures. 
Strengths  of the  DAMA trial include an approach  aimed to obtain a general modification 
of dietary and PA habits in the daily life for a relatively long period through practical activities,  
group meetings and individual counselling.  We monitored  the compliance of participants, although 
the use of self reported dietary and PA information represents a limit of this study in comparison to 
more objective measures.  
Our trial targeted  postmenopausal women enrolled from the local mammographic screening 
programme, a  well-known and long-standing organized program thus assuring  high quality and 
comparability of  mammograms (21). The evaluation of MBD assessed on digital mammograms 
through an automated software is an additional  characteristics of this trial in comparison with 
others  published so far in the same field.  
High breast density is an established risk factor for breast cancer. MBD has been considered 
as a possible intermediate endpoint in randomized trials aimed to evaluate the efficacy of specific 
interventions aimed to reduce breast cancer  risk. 
In the case-control study nested in the IBIS- I chemioprevention trial women on  tamoxifen  
who experienced a 10% or greater reduction in percent breast density  in 12-18 months have a 63% 
reduction in breast cancer risk(10). Studies in breast cancer patients on endocrine therapies 
suggested an effect on  specific mortality  and recurrence rates for   MBD reductions ranging from 
approximately 10% to more than 20% (11,12,52). Notably,  all the studies previously cited used 
two-dimensional MBD measures based on film mammograms, while we used  volumetric breast 
density measures  based on digital examinations. These measures were obtained on  different scales 
and therefore comparisons are difficult. A recent  observational study  in breast cancer patients 
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showed an association between endocrine therapies  and reduction on digitally obtained volumetric 
breast density (53) but no data are available so far, on the magnitude of the effect with a prognostic 
significance. 
A better understanding of MBD determinants might provide insight into the pathogenesis of breast 
cancer   and clues to develop strategies for primary prevention, focused on high-MBD groups 
easily identifiable in large-scale mammographic screening programs.  On the other hand,  less than  
40% of  eligible women accepted to participate thus suggesting caution in generalization of results 
and supporting  the need of further research on  strategies for sustainable lifestyle modifications 
programmes. The DAMA trial  suggests a potential effect of physical activity and dietary 
intervention in reducing MBD while results related to the  combined application of both strategies 
are less clear. Larger studies are needed to confirm these findings in order  to better clarify the role 
of MBD in the complex pathway leading to breast cancer  and the possible role of monitoring 
MBD in primary prevention programmes.  
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Table 1 Distribution (categorical variables) or mean and standard deviation (continuous variables) 
at baseline of selected characteristic, dietary and PA habits  of  participants,  overall and by study 
arm. (The DAMA  intervention trial, Florence, Italy). 
 
 
 
Whole study 
sample 
(n=226) 
Study arm  
  
Diet  
(n=57) 
Physical 
activity  
(n=54) 
Diet + 
physical 
activity  
(n=55) 
Control 
group 
(n=60) 
p-
value
a
  
Level of education       
none/primary school 64 (28.3%) 18 (31.6%) 15 (27.8%) 12 (21.8%) 19 (31.7%)  
high school 96 (42.5%) 25 (43.9%) 24 (44.4%) 24 (43.6%) 23 (38.3%)  
university 66 (29.2%) 14 (24.5%) 15 (27.8%) 19 (34.6%) 18 (30.0%) 0.85 
Smoking       
former 98 (43.4%) 25 (43.9%) 23 (42.6%) 28 (50.9%) 22 (36.7%)  
never 128 (56.6%) 32 (56.1%) 31 (57.4%) 27 (49.1%) 38 (63.3%) 0.48 
General characteristics        
Age (years) 58.7 (5.2) 58.6 (5.6) 58.6 (4.7) 58.8 (5.1) 58.8 (5.4) 0.99 
Height (cm) 159.2 (9.4) 159.2 (6.6) 159.5 (5.6) 159.5 (4.8) 158.5 (7.1) 0.77 
Weight (kg) 61.9 (9.5) 62.1 (8.2) 62.9 (9.7) 63.0 (10.6) 60.0 (9.2) 0.29 
Body Mass Index  (kg/m2) 24.4 (3.5) 24.5 (3.1) 24.8 (4.0) 24.6 (3.1) 24.7 (3.2) 0.57 
Body Mass Index (groups)       
<25 142(62.8%) 35 (61.4%) 34 (63.0%) 36 (65.5%) 37 (61.7%)  
>=25 84 (37.2%) 22 (38.6%) 20 (37.0%) 19 (34.5%) 23 (38.3%) 0.97 
Waist circumference (cm) 76.6 (7.7) 77.4 (7.1) 77.7 (7.9) 76.4 (7.6) 75.6 (8.0) 0.44 
Waist circumference (groups)       
<88 207 (91.6%) 54 (94.7%) 48 (88.9%) 50 (90.9%) 55 (91.7%)  
>=88 19 (8.4%) 3 (5.3%) 6 (11.1%) 5 (9.1%) 5 (8.3%) 0.73 
Hormonal and reproductive 
history 
            
Hormone therapy use             
never 157 (69.5%) 43 (75.4%) 36 (66.7%) 34 (61.8%) 44 (73.3%)  
ever 69 (30.5%) 14 (24.6%) 18 (33.3%) 21 (38.2%) 16 (26.7%) 0.38 
Contraceptive pill use       
never 102 (45.1%) 30 (52.6%) 20 (37.0%) 23 (41.8%) 29 (48.3%)  
ever 124 (54.9%) 27 (47.4%) 34 (63.0%) 32 (58.2%) 31 (51.7%) 0.36 
Number of children                              
0 39 (17.3%) 13 (22.8%) 10 (18.5%)  8 (14.5%) 8 (13.3%)  
1 92 (40.7%) 20 (35.1%) 19 (35.2%) 30 (54.5%) 23 (38.3%)  
2+ 95 (42.0%) 24 (42.1%) 25 (46.3%) 17 (31.0%) 29 (48.3%) 0.20 
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 Table 1 Distribution (categorical variables) or mean and standard deviation (continuous variables) 
at baseline of selected characteristic, dietary and PA habits  of  participants,  overall and by study 
arm. (The DAMA  intervention trial, Florence, Italy) (Cont’d) 
 
 
Whole study 
sample 
(n=226) 
Study arm  
  
Diet  
(n=57) 
Physical 
activity  
(n=54) 
Diet + 
physical 
activity  
(n=55) 
Control group 
(n=60) 
p-
value  
Breastfeeding         
never 37 (19.8) 12 (27.3) 6 (13.6) 10 (21.3) 9 (17.3)  
ever 150 (80.2) 32 (72.7) 38 (86.4) 37 (78.7) 43 (82.7) 0.41 
Age at first child (years) 28 (5.1) 27 (3.9) 27 (5.7) 28 (5.4) 28 (5.3) 0.65 
Age at menarche (years) 12.5 (1.4) 12.4 (1.4) 12.3 (1.2) 12.5 (1.6) 12.9 (1.4) 0.09 
Age at menopause (years) 49.9 (4.1) 49.6 (4.7) 50.4 (3.2) 50.3 (3.2) 49.3 (4.8) 0.45 
Diet       
Total vegetables (g/day) 198.5 (94.5) 188.6 (70.7) 203.8 (110.0) 203.3 (81.6) 198.9 (110.4) 0.82 
    - leafy vegetables (g/day) 35.5 (22.1) 35.3 (22.0) 35.8 (27.2) 33.1 (17.0) 37.7 (21.5) 0.74 
Fruit (g/day) 328.4 (168.3) 298.9 (154.5) 324.4 (143.8) 329.2 (158.7) 359.4 (204.8) 0.28 
Nuts, seeds and dried fruit (g/day) 2.6 (4.2) 2.2 (4.0) 2.8 (4.0) 2.9 (5.3) 2.4 (3.4) 0.77 
Legumes (g/day) 19.2 (14.6) 20.1 (19.4) 15.1 (11.1) 21.3 (14.5) 20.1 (11.4) 0.12 
Red and processed meat (g/day) 77.1 (43.2) 74.7 (36.8) 85.3 (53.6) 74.8 (38.9) 74.1 (42.2) 0.47 
Cheese (g/day) 45.8 (34.2) 38.9 (22.8) 42.6 (25.1) 58.2 (43.1) 43.8 (38.7) 0.02 
Cakes and cookies (g/day) 41.7 (50.1) 31.5 (40.3) 39.5 (35.6) 61.4 (74.1) 35.3 (36.8) 0.01 
Wine (g/day) 73.9 (100.2) 77.6 (104.3) 67.0 (97.2) 69.5 (95.2) 80.5 (105.4) 0.87 
Extra virgin olive oil (g/day) 27.5 (12.9) 26.2 ( 9.6) 29.2 (14.0) 27.5 (11.8) 27.3 (15.4) 0.67 
Kcal  2065.5 (635.5) 1925.4 (506.3) 2068.0 (650.1) 2226.5 (753.1) 2048.6 (595.7) 0.09 
Physical activity levels             
Non occupational physical activityb         
(MET-hours/week) 
89.2 (46.2) 83 (37.3) 85.7 (48.4) 90.4 (49.7) 97.0 (48.4) 0.38 
          Household physical activity  
           (MET- hours/week) 
 63.1 (40.3) 59.2 (34.5)  60.5 (42.2)  64.8 (44.6)  67.7 (40.0)   0.65 
         Recreational physical activity              
           (MET-hours-week) 
26.0 (20.2)   23.8 (15.4) 25.2 (20.4)  25.6 (18.9)  29.3 (24.6)   0.50 
At work   
 
130 (57.5) 34 (59.6) 32 (59.2) 31 (56.4) 33 (55.0) 0.96  
Physical activity at work 
sedentary 
standing 
manual 
 
79 (60.8%) 
34 (26.1%) 
17 (13.1%) 
 
24 (70.6%) 
6 (17.6%) 
4 (11.8%) 
 
18 (56.2%) 
10 (31.3%) 
4 (12.5%) 
 
20 (64.5%) 
7 (22.6%) 
4 (12.9%) 
 
17 (51.5%) 
11 (33.3%) 
5 (15.2%) 
0.61 
Total physical activity indexc 
inactive 
moderate inactive 
moderate active 
active  
 
60(26.5%) 
57 (25.2%) 
91 (40.3%) 
18 ( 8.0%) 
 
19 (33.3%) 
11 (19.3%) 
22 (38.6%) 
5 (8.8%) 
 
15 (27.8%) 
12 (22.2%) 
23 (42.6%) 
4 (7.4%) 
 
16 (29.1%) 
15 (27.3%) 
20 (36.4%) 
4 (7.3%) 
 
10 (16.7%) 
19 (31.7%) 
26 (43.3%) 
5 (8.3%) 
0.74 
a p-values were calculated from GLM for continuous variables and from X2 test for categorical variables; b
  
including 
household and recreational activities;  c the total physical activity index is categorized into four levels based on a cross-
tabulation of occupational activity by the combined household and recreational activities in  quartiles.  
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Table 2 Analysis according to single intervention arms compared to control arm (The DAMA  intervention trial, Florence, Italy)  
 
 
 Dietary intervention 
arm  
 
N=57 
Physical activity 
intervention arm 
 
N=54  
Dietary and physical 
activity intervention arm 
 
N=55 
General recommendations 
(control) arm 
 
N=60 
Volumetric percent density 
Geometric mean 
(95/%CI) 
Geometric mean 
(95%CI) 
Geometric mean 
(95%CI) 
Geometric mean  
(95%CI) 
     
Baseline 15.22 (13.85;16.74) 15.83 (14.41;17.38) 13.87 (12.47;15.42) 15.20 (13.86;16.68) 
Follow-up (at 24 months) 14.51 (13.14;16.02) 15.01 (13.61;16.57) 13.64 (12.26;15.19) 15.35 (14.01;16.82) 
Follow-up adjusted
a
 13.54 (12.94;14.18) 13.76 (13.14;14.41) 14.06 (13.41;14.73) 14.84 (14.24;15.47) 
Ratio
 b
 (95% CI) 0.91 (0.86;0.97) 0.93 (0.87; 0.98) 0.95 (0.89;1.00) 1 
p value 
 
p = 0.003 p = 0.01 p = 0.08 - 
 
  
aAdjusted for weight change, volumetric percent  density (VPD) log-trasformed at baseline, randomization block variables   
b  Ratio of the adjusted geometric means  at follow-up 
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Table 3  Estimated changes in consumption of selected food (g/day)  and kilocalories and in leisure time PA 
 (MET hours/week) at the end of the intervention in comparison to baseline  by arms. (The DAMA intervention trial, Florence, Italy)  
 
  
Diet  
(n=57) 
Physical activity  
(n=54) 
Diet + physical activity  
(n=55) 
Control group 
(n=60) 
 
Absolute  
difference  
(%) 
pa 
Absolute  
difference  
(%) 
p 
Absolute  
difference  
(%) 
 
p 
 
Absolute  
difference  
(%) 
Food gropus (g/day)        
Total vegetables  
40.0 
(21.2) 
0.06 
-14.7 
(-7.2) 
0.17 
45.8 
(22.5) 
0.01 
8.7  
(4.4) 
    - leafy vegetables  
8.8 
(24.9) 
0.29 
1.9 
(5.3) 
0.63 
14.6 
(44.1) 
0.02 
4.1 
(10.9) 
        
Fresh fruit  
24.8 
 (8.3) 
0.72 
13.9 
 (4.3) 
0.70 
-20.8 
(6.3) 
0.39 
-12.0 
(3.3) 
        
Nuts, seeds and dried fruit 
2.9 
(131.8) 
0.16 
-0.1 
(3.6) 
0.12 
1.9 
(65.5) 
0.73 
1.5 
(62.5) 
        
Legumes 
19.8 
(98.5) 
<0.0001 
4.5 
(29.8) 
0.94 
14.3 
(67.1) 
0.0008 
2.0 
(10.0) 
        
Red and processed meat 
-41.6 
(55.7) 
<0.0001 
-26.2 
(30.7) 
0.49 
-43.2 
(57.8) 
<0.0001 
-20.5 
(27.7) 
        
Cheese 
-13.3 
(34.2) 
0.40 
-8.3 
(19.5) 
0.98 
-21.4 
(36.8) 
0.03 
-8.2 
(18.7) 
        
Cakes and cookies 
-13.4 
(42.5) 
0.006 
-8.4 
(21.3) 
0.04 
-32.6 
(53.1) 
0.004 
17.9 
(50.7) 
 
 
 
 
on August 21, 2018. © 2018 American Association for Cancer Research.cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on August 1, 2018; DOI: 10.1158/1055-9965.EPI-18-0468 
 27 
Table 3  Estimated changes in consumption of selected food (g/day)  and kilocalories and in leisure time PA 
 (MET hours/week) at the end of the intervention in comparison to baseline  by arms. (The DAMA intervention trial, Florence, Italy) (Cont’d) 
 
 
 
  
Diet  
(n=57) 
Physical activity  
(n=54) 
Diet + physical activity  
(n=55) 
Control group 
(n=60) 
 
 
Difference  
(%) 
p 
 
Difference  
(%) 
p 
 
Difference  
(%) 
 
p 
 
 
Difference  
(%) 
        
Wine 
-13.6 
(17.5) 
0.25 
0.2 
 (0.3) 
0.60 
-21.6 
(31.1) 
0.02 
-4.4 
(5.5) 
        
Extra virgin olive oil 
4.6 
(17.5) 
0.22 
-2.9 
(9.9) 
0.10 
4.3 
(15.6) 
0.16 
1.4 
(5.1) 
        
kilocalories 
-162.6 
(8.4) 
0.10 
-107.1 
(5.2) 
0.27 
-294.6 
(13.2) 
0.005 
12.3 
(0.6) 
        
Leisure time physival activity 
(MET-hours-week) 
 
       
Overall leisure time physical activity           
2.9 
(4.3) 
0.44 
10.4 
(12.0) 
0.09 
16.9 
(18.7) 
0.01 
-3.0 
(3.1) 
        
         - Household physical activity 
2.1 
(3.5) 
0.27 
-1.4 
(2.3) 
0.63 
2.4 
(3.7) 
0.26 
-4.3 
(6.3) 
        - Recreational physical activity              
 
0.8 
(3.4) 
0.89 
11.8 
(46.8) 
0.01 
14.5 
(56.6) 
0.002 
1.3 
(4.4) 
        
 
a p-values were calculated from GLM comparing each intervention arm with the control arm.  
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Figure Legends 
 
Figure 1  
Recruitment of participants, randomization and follow-up in the DAMA intervention trial.  
CONSORT Flow Diagram showing procedures of selection among eligible women and participants with complete data available. 
 
 
Figure 2  
The main outcome in the DAMA trial. Geometric Mean (+ SD) of Volumetric Percent Density measured at baseline and follow-up mammographic 
examination in women randomized to dietary (D), physical activity (PA) and double intervention arms (D+PA) and in controls (C).  
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